Appropriate prescribing is an essential medical practice of physicians. However, physicians prescribing behaviors are likely to be affected by promotional activities of pharmaceutical industries and their representatives. In this paper, we sought to explore where physicians obtain information on pharmaceutical medicines; factors influencing their medication prescriptions; and experiences of prescribing. Three public hospitals and 28 doctors were purposively sampled. Structured in-depth interviews were conducted and data were transcribed and analyzed thematically. Results show that pharmaceutical representatives are the main sources of information on pharmaceutical drugs. Patient factors such as financial status; medical diagnosis and condition; and type of patient influenced physicians’ prescribing practices. Physicians’ experiences on drug prescription practices were mixed. Requests for prescriptions were mostly for over-the-counter medicines. Majority of physicians reported that patients’ noncompliance to prescriptions was due to perceived superiority of alternative plant medicines. There is a need for stricter regulation on marketing nonprescribed pharmaceutical products to avoid fatal health implications through consumption of nonprescribed medicines.
McGettiganPGoldenJFryerJ. Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol2000; 51: 184–189.
4.
VitryAI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol2007; 63: 709–714.
5.
HaugJD. Physicians preferences for information sources: A meta analytic study. Bull Med Libr Assoc1997; 85(3): 223–232.
6.
FrankeLAveryAJGroomL. Is there a role for computerized decision support for drug dosing in general practice? A questionnaire survey. J Clin Pharm Ther2000; 25: 373–377.
7.
CockburnJPitS. Prescribing behavior in clinical practice: Patients’ expectations and doctors’ perceptions of patients’ expectation - a questionnaire study. Br Med J1997; 315: 520–523.
8.
WazanaA. Physicians and the pharmaceutical industry: Is a gift ever just a gift?J Am Med Assoc2000; 283: 391–393.
9.
ManchandaP. and Honka E. The effects and role of direct-to-physician marketing in the pharmaceutical industry: An integrative review. Yale J Health Policy Law Ethics2005; 5: 785–822.
10.
FeelyJChanRMcManusJ. The influence of hospital-based prescribers on prescribing in general practice. Pharmacoeconomics1999; 16: 175–181.
11.
JonesMIGreenfieldMBradleyC. Prescribing new drugs: Qualitative study of influences on consultants and general practitioners. Br Med J2001; 323: 378–396.
12.
SpurlingGKMansfieldPRMontgomeryBD. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: A systematic review. PLoS Med2010; 7(10): e1000352–e1000352.
13.
MorganMADanaJLoewensteinG. Interactions of doctors with the pharmaceutical industry. J Med Ethics2006; 32: 559–563.
14.
FischerMAKeoughMEBarilJL. Prescribers and pharmaceutical representatives: Why are we still meeting?J Gen Intern Med2009; 24: 795–801.
15.
ZipkinDASteinmanMA. Interactions between pharmaceutical representatives and doctors in training. A thematic review. J Gen Intern Med2005; 20: 777–786.
16.
GonulFCarterFPetrovaE. Promotion of prescription drugs and its impact on physicians’ choice behavior. J Market2001; 65: 79–90.
17.
NarendranRNarendranathanM. Influence of pharmaceutical marketing on prescription practices of physicians. J Ind Med Assoc2013; 111(1): 47–50.
18.
SteinmanMAShlipakMGMcPheeSJ. Of principles and pens: Attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am Med J2001; 110: 551–557.
19.
RutledgePCrookesDMcKinstryB. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey. Pharmacoepidemiol Drug Saf2003; 12: 663–667.
20.
Vakratsas D and Kalyanaram G. Price effects on physician prescription behavior and the role of HMO orientation 2011. Working paper no. 10912011, 2011.
21.
Kaiser Family Foundation. Prescription drugs: Advertising, out-of-pocket costs, and patient safety from the perspective of doctors and pharmacists, http://www.kff.org/kaiserpolls/upload/7583.pdf (2006, accessed 1 March 2001).
22.
ProsserHAlmondSWalleyT. Influences on GP’s decision to prescribe new drugs - the importance of who says what. J Fam Pract2003; 20(1): 61–68.
23.
ProsserHWalleyT. New drug uptake: Qualitative comparison of high and low prescribing GPs’ attitudes and approach. J Fam Pract2003; 20: 583–591.
24.
De AllegriMSanonMBridgesJ. Understanding consumers’ preferences and decision to enroll in community-based health insurance in rural West Africa. Health Policy2006; 76: 58–71.
25.
Hardon AP, Boonmongkon P, Streefland P, et al. Focus group discussions. In: Hayes E (ed.) Applied health research anthropology of health care. Amsterdam: Het Spinhuis Publishers, 2001.
26.
Strauss A and Corbin J. Basics of qualitative research. In: Techniques and procedures for developing the grounded theory. 2nd ed. Thousand Oaks, CA: Sage Publications, 1990.
27.
KisaS. Factors that influence prescribing decisions among Turkish physicians. Clin Res Regulat Affairs2006; 23(3–4): 177–189.
28.
CreyerEHrsistodoulakisI. Marketing pharmaceutical products to physicians: Sales reps influence physicians impressions of the industry. Market Health Serv1998; 18(2): 34–38.
29.
MurrayM. Process improvement and supply and demand: The elements that underlie integration. Healthcare Quart2009; 13: 37–42.
30.
World Health Organization. Preparing a health care workforce for the 21st century: The challenge of chronic conditions, Geneva: World Health Organization, 2005.
31.
VermeireEHeinshawHVan RoyenP. Patient adherence to treatment; three decades of research. A comprehensive review. J Clin Pharm Ther2001; 26: 331–342.
32.
Anon. Working party from compliance to concordance. Achieving shared goals in medicine taking, London: Royal Pharmaceutical Society of Great Britain, 1997.
33.
HaynesRBMcKibbonKAKannaiR. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet1996; 348: 383–386.
34.
Vasquez-LagoJMLopez-VasquezPLopez-DuranA. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: A qualitative study from Spain. J Fam Pract2012; 29: 352–360.
